Patents by Inventor Benjamin Belinka

Benjamin Belinka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment and diagnosis of inflammatory disorders and HIV
    Patent number: 10226506
    Abstract: This invention concerns compositions and methods of treating or diagnosing inflammatory disorders and other disorders, as well as compositions and methods of treating HIV.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: March 12, 2019
    Assignees: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, ACTINOBAC BIOMED, INC.
    Inventors: Scott C. Kachlany, Benjamin Belinka
  • Treatment and diagnosis of ocular disease
    Patent number: 9950030
    Abstract: This invention concerns compositions and methods of treating or diagnosing ocular disease.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: April 24, 2018
    Assignees: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, ACTINOBAC BIOMED, INC.
    Inventors: Scott Kachlany, Benjamin Belinka
  • TREATMENT AND DIAGNOSIS OF INFLAMMATORY DISORDERS AND HIV
    Publication number: 20180104305
    Abstract: This invention concerns compositions and methods of treating or diagnosing inflammatory disorders and other disorders, as well as compositions and methods of treating HIV.
    Type: Application
    Filed: December 6, 2017
    Publication date: April 19, 2018
    Inventors: Scott C. Kachlany, Benjamin Belinka
  • Treatment and diagnosis of inflammatory disorders and HIV
    Patent number: 9849156
    Abstract: This invention concerns compositions and methods of treating or diagnosing inflammatory disorders and other disorders, as well as compositions and methods of treating HIV.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: December 26, 2017
    Assignees: RUTGERS, THE STATE UNIVERSIT OF NEW JERSEY, ACTINOBAC BIOMED, INC.
    Inventors: Scott Kachlany, Benjamin Belinka
  • Methods to treat inflammation of the lung
    Patent number: 9724384
    Abstract: The present invention provides pharmaceutical compositions comprising leukotoxin for the treatment of lung inflammation.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: August 8, 2017
    Assignees: Rutgers, the State University of New Jersey, Actinobac Biomed, Inc.
    Inventors: Scott Kachlany, Benjamin Belinka
  • TREATMENT AND DIAGNOSIS OF INFLAMMATORY DISORDERS AND HIV
    Publication number: 20160339077
    Abstract: This invention concerns compositions and methods of treating or diagnosing inflammatory disorders and other disorders, as well as compositions and methods of treating HIV.
    Type: Application
    Filed: March 24, 2016
    Publication date: November 24, 2016
    Inventors: Scott Kachlany, Benjamin Belinka
  • TREATMENT AND DIAGNOSIS OF OCULAR DISEASE
    Publication number: 20160287662
    Abstract: This invention concerns compositions and methods of treating or diagnosing ocular disease.
    Type: Application
    Filed: June 27, 2014
    Publication date: October 6, 2016
    Inventors: Scott Kachlany, Benjamin Belinka
  • Combination therapy with leukotoxin
    Patent number: 9352017
    Abstract: The invention relates to pharmaceutical compositions comprising leukotoxin, a chemotherapeutic agent and a pharmaceutically acceptable carrier, including methods to treat cancer, and methods to induce apoptosis.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: May 31, 2016
    Assignees: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, ACTINOBAC BIOMED, INC.
    Inventors: Scott Kachlany, Benjamin Belinka
  • METHODS TO TREAT INFLAMMATION OF THE LUNG
    Publication number: 20150366937
    Abstract: The present invention provides pharmaceutical compositions comprising leukotoxin for the treatment of lung inflammation.
    Type: Application
    Filed: June 19, 2015
    Publication date: December 24, 2015
    Applicants: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Scott Kachlany, Benjamin Belinka
  • Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
    Publication number: 20070010441
    Abstract: This invention relates to proteins (e.g., peptides) that are capable of facilitating transport of an active agent through a human or animal gastro-intestinal tissue, and derivatives (e.g., fragments) and analogs thereof, and nucleotide sequences coding for said proteins and derivatives. The proteins of the invention have use in facilitating transport of active agents from the lumenal side of the GIT into the systemic blood system, and/or in targeting active agents to the GIT. Thus, for example, by binding (covalently or noncovalently) a protein of the invention to an orally administered drug, the drug can be targeted to specific receptor sites or transport pathways which are known to operate in the human gastrointestinal tract, thus facilitating its absorption into the systemic system.
    Type: Application
    Filed: February 17, 2006
    Publication date: January 11, 2007
    Inventors: Vernon Alvarez, Daniel O'Mahony, Imelda Lambkin, Catherine Patterson, Judith Singleton, Benjamin Belinka, John Carter, Gerard Cagney